Evidence map›Paper›PMID 40156857›Full record

ArticleNucleic acids research2025

Precision genome editing and in-cell measurements of oxidative DNA damage repair enable functional and mechanistic characterization of cancer-associated MUTYH variants.

Carlos A Vasquez, Nicola R B Osgood, Marcanthony U Zepeda, Dominika K Sandel, Quinn T Cowan, Malalage N Peiris, Daniel J Donoghue, Alexis C Komor

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Carlos A VasquezDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093, United States.ORCID 0000-0002-1965-8457
Nicola R B OsgoodDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093, United States.ORCID 0000-0002-1481-6903
Marcanthony U ZepedaDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093, United States.ORCID 0009-0006-9494-6113
Dominika K SandelDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093, United States.ORCID 0009-0003-7851-6066
Quinn T CowanDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093, United States.ORCID 0000-0002-8697-8178
Malalage N PeirisDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093, United States.
Daniel J DonoghueDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093, United States.ORCID 0000-0002-4546-2175
Alexis C KomorDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093, United States.ORCID 0000-0001-5043-0998

Funding

Contemporary Approaches to Cancer Cell Signaling and CommunicationT32CA009523 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DONOGHUE, DANIEL J, YANG, JING · 1985 to 2025
$12.1M
MOLECULAR BIOPHYSICS TRAINING PROGRAMT32GM008326 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KOMIVES, ELIZABETH A. · 1989 to 2020
$7.5M
Cancer Cell Signaling and Communication Training ProgramHoward Hughes Medical InstituteMolecular Biophysics TrainingNational Academies of Sciences, Engineering, and MedicineNCI NIH HHS T32 CA009523NIGMS NIH HHS T32 GM008326NIH HHS T32 CA009523Research Corporation for Science Advancement 27502University of California, San Diego
6 · The paper itself

Abstract

Functional characterization of genetic variants has the potential to advance the field of precision medicine by enhancing the efficacy of current therapies and accelerating the development of new approaches to combat genetic diseases. MUTYH is a DNA repair enzyme that recognizes and repairs oxidatively damaged guanines [8-oxoguanine (8-oxoG)] mispaired with adenines (8-oxoG·A). While some mutations in the MUTYH gene are associated with colorectal cancer, most MUTYH variants identified in sequencing databases are classified as variants of uncertain significance. Convoluting clinical classification is the absence of data directly comparing homozygous versus heterozygous MUTYH mutations. In this study, we present the first effort to functionally characterize MUTYH variants using precision genome editing to generate heterozygous and homozygous isogenic cell lines. Using a MUTYH-specific lesion reporter in which we site-specifically incorporate an 8-oxoG·A lesion in a fluorescent protein gene, we measure endogenous MUTYH enzymatic activity and classify them as pathogenic or benign. Further, we modify this reporter to incorporate the MUTYH repair intermediate (8-oxoG across from an abasic site) and validate it with co-immunoprecipitation experiments to demonstrate its ability to characterize the mechanism by which MUTYH mutants are defective at DNA repair.

Indexed as

DNA DamageDNA GlycosylasesDNA RepairGene EditingNeoplasmsCell Line, TumorColorectal NeoplasmsCRISPR-Cas SystemsGenes, ReporterGuanineHumansMutationOxidative Stress8-hydroxyguanineDNA GlycosylasesGuaninemutY adenine glycosylase

Identifiers

PMID40156857
PMCPMC11952967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.